Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ann Thor

Concepts (458)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
72
2023
2420
3.860
 Why?
Neoplasms, Germ Cell and Embryonal
8
2026
76
2.630
 Why?
Testicular Neoplasms
8
2026
111
2.600
 Why?
Metformin
10
2018
329
1.990
 Why?
Lymph Node Excision
6
2026
173
1.770
 Why?
Tamoxifen
11
2023
193
1.590
 Why?
Receptors, Estrogen
17
2020
406
1.450
 Why?
Thyroid Hormones
2
2023
69
1.390
 Why?
Seminoma
3
2026
20
1.330
 Why?
Receptor, ErbB-3
8
2016
48
1.210
 Why?
Biomarkers, Tumor
17
2024
1339
1.210
 Why?
Lymphatic Metastasis
18
2024
338
1.180
 Why?
Cell Proliferation
16
2023
2529
1.160
 Why?
Genes, erbB-2
8
2013
32
1.020
 Why?
Cell Cycle
5
2023
600
1.010
 Why?
Mammary Neoplasms, Experimental
6
2017
62
0.980
 Why?
MicroRNAs
6
2024
694
0.890
 Why?
Apoptosis
21
2018
2454
0.850
 Why?
Estrogen Receptor alpha
3
2023
154
0.830
 Why?
Estrogens
2
2023
368
0.750
 Why?
Cell Line, Tumor
23
2023
3565
0.750
 Why?
ErbB Receptors
6
2010
638
0.630
 Why?
Up-Regulation
3
2020
848
0.620
 Why?
Hormone Replacement Therapy
1
2020
109
0.590
 Why?
Immunohistochemistry
26
2020
1730
0.580
 Why?
Mammary Neoplasms, Animal
3
2018
35
0.560
 Why?
Triple Negative Breast Neoplasms
3
2016
220
0.550
 Why?
Caspases
5
2009
233
0.540
 Why?
Disease-Free Survival
11
2020
779
0.540
 Why?
Tumor Suppressor Protein p53
14
2011
536
0.510
 Why?
Retroperitoneal Space
3
2026
19
0.500
 Why?
Gene Expression Regulation, Neoplastic
18
2021
1457
0.470
 Why?
Antineoplastic Agents
10
2018
2231
0.460
 Why?
Prognosis
21
2020
4383
0.460
 Why?
Claudins
1
2016
23
0.460
 Why?
Receptor, IGF Type 1
3
2016
64
0.440
 Why?
Drug Resistance, Neoplasm
10
2023
889
0.440
 Why?
Trastuzumab
8
2016
119
0.420
 Why?
Quinazolines
3
2026
266
0.410
 Why?
Transcriptome
1
2020
1059
0.400
 Why?
Carcinogenesis
1
2016
230
0.400
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
2001
0.400
 Why?
Carcinoma, Ductal, Breast
5
2002
91
0.400
 Why?
Signal Transduction
16
2023
5272
0.400
 Why?
Postoperative Complications
1
2026
3022
0.380
 Why?
Estradiol
2
2009
515
0.380
 Why?
Genistein
2
2010
13
0.370
 Why?
Receptors, Steroid
2
2012
42
0.370
 Why?
Humans
95
2026
147293
0.370
 Why?
Hypoglycemic Agents
3
2017
1415
0.360
 Why?
Female
69
2026
80076
0.350
 Why?
Doxorubicin
10
2011
411
0.350
 Why?
Antineoplastic Agents, Hormonal
5
2020
196
0.340
 Why?
Antimetabolites, Antineoplastic
1
2012
108
0.340
 Why?
Receptors, Progesterone
6
2020
244
0.330
 Why?
Sweden
3
2026
117
0.320
 Why?
Teratoma
2
2022
124
0.310
 Why?
STAT3 Transcription Factor
1
2012
215
0.310
 Why?
Neoplasm Invasiveness
7
2016
512
0.310
 Why?
Genes, p53
5
2000
67
0.310
 Why?
Neoplasm Staging
9
2024
1492
0.300
 Why?
Mice
18
2023
18491
0.300
 Why?
Neoplasm Proteins
5
2016
445
0.290
 Why?
Glucose
1
2013
1051
0.270
 Why?
Middle Aged
33
2026
36821
0.270
 Why?
Glycoproteins
2
2005
358
0.260
 Why?
Intracellular Signaling Peptides and Proteins
2
2010
459
0.260
 Why?
Mammary Tumor Virus, Mouse
2
2004
42
0.260
 Why?
Mice, Transgenic
8
2018
2197
0.250
 Why?
MCF-7 Cells
4
2020
133
0.240
 Why?
Carcinoma
4
1995
231
0.240
 Why?
Ejaculation
1
2026
11
0.240
 Why?
Neoplasm, Residual
2
2024
144
0.240
 Why?
Animals
23
2023
38410
0.240
 Why?
Antibodies, Monoclonal
7
2013
1514
0.230
 Why?
Bromodeoxyuridine
2
1999
77
0.230
 Why?
Thiophenes
1
2026
117
0.220
 Why?
Multivariate Analysis
8
2005
1550
0.220
 Why?
Polymerase Chain Reaction
6
2021
1046
0.220
 Why?
Predictive Value of Tests
6
2024
2133
0.220
 Why?
Protein Kinase Inhibitors
3
2016
984
0.220
 Why?
Enzyme Activation
4
2009
762
0.210
 Why?
Intraoperative Complications
1
2026
158
0.210
 Why?
Tyrosine
2
2007
218
0.210
 Why?
Radiation Tolerance
1
2005
103
0.210
 Why?
Xenograft Model Antitumor Assays
3
2020
939
0.200
 Why?
Phosphorylation
5
2011
1721
0.200
 Why?
Cocarcinogenesis
1
2003
13
0.200
 Why?
Isoflavones
1
2003
25
0.190
 Why?
Cell Survival
5
2018
1111
0.190
 Why?
Survival Analysis
8
2005
1386
0.190
 Why?
Paclitaxel
4
2015
261
0.190
 Why?
Adult
22
2026
41405
0.190
 Why?
Chromosomes
1
2003
106
0.180
 Why?
Fluorouracil
6
2026
232
0.180
 Why?
Ki-67 Antigen
4
2014
120
0.180
 Why?
Cyclins
2
2000
79
0.180
 Why?
Chromosomes, Human, Pair 8
1
2002
40
0.180
 Why?
Gelsolin
1
2001
11
0.170
 Why?
Chromosome Aberrations
1
2002
168
0.170
 Why?
Orchiectomy
1
2021
72
0.170
 Why?
Proto-Oncogene Proteins c-ets
2
2020
56
0.170
 Why?
Cyclophosphamide
7
2011
277
0.170
 Why?
Breast
4
2018
157
0.160
 Why?
Retroperitoneal Neoplasms
1
2021
28
0.160
 Why?
Rats
7
2022
5613
0.160
 Why?
Caspase 3
4
2006
242
0.160
 Why?
DNA-Binding Proteins
3
2020
1488
0.160
 Why?
Diet
3
2018
1284
0.160
 Why?
Etoposide
1
2001
169
0.160
 Why?
Cell Division
6
2005
758
0.160
 Why?
Obesity
4
2022
3149
0.150
 Why?
Neoplastic Stem Cells
2
2014
409
0.150
 Why?
Mice, SCID
1
2020
369
0.150
 Why?
Phosphatidylinositol 3-Kinases
3
2011
383
0.150
 Why?
Drug Screening Assays, Antitumor
3
2016
194
0.150
 Why?
Proto-Oncogene Proteins
5
2008
627
0.150
 Why?
Transcription Factors
3
2020
1747
0.150
 Why?
TOR Serine-Threonine Kinases
3
2012
456
0.150
 Why?
Treatment Outcome
6
2026
11947
0.150
 Why?
Mitotic Index
1
1999
25
0.140
 Why?
Carcinoma, Papillary
1
1999
83
0.140
 Why?
Prospective Studies
4
2024
8164
0.140
 Why?
Mice, Inbred NOD
1
2020
616
0.140
 Why?
Receptors, Androgen
2
2017
149
0.140
 Why?
Antigens, Neoplasm
2
2009
273
0.140
 Why?
Chemotherapy, Adjuvant
5
2015
429
0.140
 Why?
Tumor Cells, Cultured
6
2009
891
0.140
 Why?
Ovarian Neoplasms
4
1995
599
0.140
 Why?
Drug Synergism
3
2018
355
0.140
 Why?
Aromatase
1
2018
37
0.140
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
59
0.130
 Why?
Kaplan-Meier Estimate
1
2020
975
0.130
 Why?
HSP90 Heat-Shock Proteins
1
2018
47
0.130
 Why?
Phenylthiohydantoin
2
2017
44
0.130
 Why?
Down-Regulation
3
2010
618
0.130
 Why?
Colorectal Neoplasms
1
2026
876
0.130
 Why?
Autism Spectrum Disorder
1
2023
425
0.130
 Why?
In Situ Hybridization, Fluorescence
4
2008
330
0.130
 Why?
Ovariectomy
4
2022
166
0.130
 Why?
Tumor Burden
4
2022
327
0.130
 Why?
Poly(ADP-ribose) Polymerases
2
2009
88
0.130
 Why?
Organic Cation Transport Proteins
1
2017
25
0.120
 Why?
Postmenopause
5
2022
394
0.120
 Why?
Triazoles
1
2018
191
0.120
 Why?
Antibodies, Monoclonal, Humanized
5
2013
1005
0.120
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
231
0.120
 Why?
Smad Proteins
1
2016
42
0.120
 Why?
Cathepsin D
2
2002
22
0.110
 Why?
Gene Knock-In Techniques
1
2016
61
0.110
 Why?
Calcitriol
1
2016
59
0.110
 Why?
Ovary
1
2017
236
0.110
 Why?
Antibiotics, Antineoplastic
3
2009
141
0.110
 Why?
Proteins
2
1992
1024
0.110
 Why?
Gene Amplification
2
2009
118
0.110
 Why?
Male
9
2026
73950
0.110
 Why?
Protein Tyrosine Phosphatases
1
2016
167
0.110
 Why?
Fatty Acid Synthase, Type I
1
2014
11
0.110
 Why?
Immunoradiometric Assay
1
1994
1
0.100
 Why?
Immunoprecipitation
2
2011
149
0.100
 Why?
Androgen Receptor Antagonists
1
2014
35
0.100
 Why?
Mental Disorders
1
2023
1188
0.100
 Why?
Young Adult
4
2024
14437
0.100
 Why?
Postpartum Period
2
2014
379
0.100
 Why?
Disease Progression
6
2018
2890
0.100
 Why?
Insulin-Like Growth Factor I
1
2016
318
0.100
 Why?
Mice, Knockout
1
2020
3153
0.100
 Why?
Receptor, ErbB-4
2
2010
19
0.100
 Why?
Androgen Antagonists
1
2014
91
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
64
0.100
 Why?
Transforming Growth Factor beta
1
2016
475
0.090
 Why?
Retrospective Studies
5
2026
17560
0.090
 Why?
Blotting, Western
3
2011
1186
0.090
 Why?
Adenocarcinoma
3
2012
928
0.090
 Why?
Aged
15
2026
26514
0.090
 Why?
Overnutrition
1
2012
28
0.090
 Why?
Vitamin D
1
2016
405
0.090
 Why?
Nucleic Acid Hybridization
2
2003
188
0.090
 Why?
DNA, Neoplasm
6
2005
163
0.090
 Why?
Aminosalicylic Acids
1
2012
10
0.090
 Why?
Benzenesulfonates
1
2012
23
0.090
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
61
0.090
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
241
0.090
 Why?
Chromones
1
2011
43
0.090
 Why?
Gene Expression Profiling
2
2016
1794
0.090
 Why?
RNA, Messenger
4
2016
2812
0.090
 Why?
Genital Diseases, Female
1
1991
31
0.080
 Why?
Disease Models, Animal
4
2017
4604
0.080
 Why?
Dasatinib
1
2011
58
0.080
 Why?
Fluoxymesterone
1
1991
1
0.080
 Why?
Apoptosis Regulatory Proteins
1
2012
187
0.080
 Why?
Mitosis
3
2001
194
0.080
 Why?
Proportional Hazards Models
4
2005
1344
0.080
 Why?
S Phase
2
2010
78
0.080
 Why?
Reagent Kits, Diagnostic
1
1991
33
0.080
 Why?
Thiazoles
1
2011
142
0.080
 Why?
Morpholines
1
2011
130
0.080
 Why?
Cohort Studies
2
2020
6099
0.080
 Why?
Weight Gain
3
2022
566
0.080
 Why?
Chromosomes, Human, Pair 17
3
2002
54
0.080
 Why?
Proto-Oncogenes
1
1989
28
0.080
 Why?
Genital Neoplasms, Female
1
1991
100
0.080
 Why?
Neoplasm Metastasis
5
2005
695
0.080
 Why?
Dose-Response Relationship, Drug
2
2008
2030
0.070
 Why?
Radioisotopes
1
1989
37
0.070
 Why?
Flow Cytometry
3
2007
1172
0.070
 Why?
DNA Topoisomerases, Type II
1
2009
42
0.070
 Why?
Anthracyclines
1
2009
49
0.070
 Why?
Follow-Up Studies
5
2020
5476
0.070
 Why?
Aged, 80 and over
6
2002
8430
0.070
 Why?
Gene Deletion
2
2002
392
0.070
 Why?
MAP Kinase Signaling System
1
2010
308
0.070
 Why?
AMP-Activated Protein Kinases
1
2009
192
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
980
0.070
 Why?
Pyrimidines
1
2011
532
0.070
 Why?
RNA, Small Interfering
2
2007
643
0.070
 Why?
Mice, Nude
1
2009
680
0.060
 Why?
Gene Dosage
1
2008
145
0.060
 Why?
Epithelial Cells
1
2014
1141
0.060
 Why?
Mutation
3
1995
4130
0.060
 Why?
Protein Structure, Tertiary
1
2009
855
0.060
 Why?
Reproducibility of Results
3
2023
3448
0.060
 Why?
Immunoenzyme Techniques
3
1999
200
0.060
 Why?
Time Factors
4
2015
7173
0.060
 Why?
Energy Metabolism
1
2012
936
0.060
 Why?
Proto-Oncogene Proteins c-akt
3
2016
440
0.060
 Why?
Enzyme Precursors
1
2006
15
0.060
 Why?
Thymidylate Synthase
1
2026
13
0.060
 Why?
Cell Nucleus
4
2006
589
0.060
 Why?
Receptor, Notch1
1
2006
63
0.060
 Why?
Aging
4
2003
1992
0.060
 Why?
Multigene Family
2
2003
210
0.060
 Why?
Lamin Type B
1
2005
6
0.060
 Why?
Epigenesis, Genetic
1
2010
708
0.060
 Why?
Mitochondria
3
2008
1000
0.050
 Why?
Herpes Simplex
1
2006
102
0.050
 Why?
Cell Nucleolus
1
2005
20
0.050
 Why?
Survival Rate
4
2020
2110
0.050
 Why?
Herpesvirus 1, Human
1
2006
87
0.050
 Why?
Age Factors
3
2003
3372
0.050
 Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
106
0.050
 Why?
Benzamides
2
2017
227
0.050
 Why?
Antineoplastic Agents, Phytogenic
2
2007
178
0.050
 Why?
Nitriles
2
2017
211
0.050
 Why?
Feedback
1
2005
181
0.050
 Why?
RNA Interference
3
2015
477
0.050
 Why?
Protein Kinases
1
2006
312
0.050
 Why?
Tacrolimus Binding Protein 1A
1
2003
10
0.050
 Why?
Tacrolimus Binding Proteins
1
2003
25
0.050
 Why?
Rats, Wistar
2
2017
450
0.050
 Why?
Tumor Microenvironment
2
2018
748
0.050
 Why?
Mice, Inbred Strains
1
2004
397
0.050
 Why?
Estrogens, Non-Steroidal
1
2003
10
0.050
 Why?
Genes, Tumor Suppressor
1
2003
86
0.050
 Why?
Phytoestrogens
1
2003
17
0.050
 Why?
Adipose Tissue
2
2018
646
0.050
 Why?
Estrogen Antagonists
1
2003
37
0.050
 Why?
Plant Preparations
1
2003
37
0.050
 Why?
Cell Line
2
2003
2832
0.050
 Why?
Actins
1
2005
428
0.050
 Why?
Anticarcinogenic Agents
1
2003
63
0.050
 Why?
Chromosome Banding
1
2002
20
0.050
 Why?
Chromosomes, Human, Pair 16
1
2002
36
0.050
 Why?
Mammary Glands, Animal
1
2003
128
0.050
 Why?
Embryoid Bodies
1
2022
8
0.050
 Why?
3' Untranslated Regions
2
2014
149
0.040
 Why?
Transfection
3
2015
930
0.040
 Why?
Rodentia
1
2022
62
0.040
 Why?
Trefoil Factor-1
2
1992
2
0.040
 Why?
Fallopian Tubes
2
1991
33
0.040
 Why?
alpha-Fetoproteins
1
2021
42
0.040
 Why?
In Situ Nick-End Labeling
1
2001
120
0.040
 Why?
Chorionic Gonadotropin
1
2021
78
0.040
 Why?
RNA, Catalytic
1
2002
191
0.040
 Why?
Nuclear Proteins
2
2000
745
0.040
 Why?
DNA Fragmentation
1
2001
43
0.040
 Why?
Plasmids
1
2002
373
0.040
 Why?
Inhibitory Concentration 50
1
2001
91
0.040
 Why?
Fibrosis
1
2023
568
0.040
 Why?
Antigens, Nuclear
1
2000
15
0.040
 Why?
RNA Stability
1
2021
108
0.040
 Why?
Breast Diseases
1
2000
23
0.040
 Why?
Enhancer Elements, Genetic
1
2000
191
0.040
 Why?
Integrin beta3
2
2013
14
0.040
 Why?
Telomerase
1
2001
250
0.040
 Why?
Tumor Suppressor Proteins
2
1992
323
0.040
 Why?
N-Glycosyl Hydrolases
1
1998
6
0.040
 Why?
Methylnitrosourea
1
2018
7
0.030
 Why?
DNA Glycosylases
1
1998
10
0.030
 Why?
Loss of Function Mutation
1
2018
46
0.030
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
44
0.030
 Why?
Trans-Activators
1
2000
398
0.030
 Why?
Antibodies
1
2000
398
0.030
 Why?
Codon
3
1993
92
0.030
 Why?
NF-kappa B
1
2002
676
0.030
 Why?
Half-Life
1
2018
157
0.030
 Why?
Case-Control Studies
2
2023
3660
0.030
 Why?
Stromal Cells
1
2018
123
0.030
 Why?
Hyaluronan Receptors
1
1998
105
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
165
0.030
 Why?
Gene Expression
3
2013
1481
0.030
 Why?
Organic Cation Transporter 2
1
2017
8
0.030
 Why?
Extracellular Matrix Proteins
1
1998
156
0.030
 Why?
Cell Movement
1
2001
966
0.030
 Why?
Steroids
1
2017
162
0.030
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
14
0.030
 Why?
Antigens, CD
2
2014
562
0.030
 Why?
DNA Repair
1
1998
256
0.030
 Why?
Oncogenes
1
2016
118
0.030
 Why?
Phosphatidylinositol 3-Kinase
1
2015
25
0.030
 Why?
Chromatography, Liquid
1
2017
453
0.030
 Why?
Oncogene Proteins
1
1995
62
0.030
 Why?
RNA
1
2001
916
0.030
 Why?
Analysis of Variance
2
2014
1302
0.030
 Why?
Homeodomain Proteins
1
2018
525
0.030
 Why?
Tosyl Compounds
1
2014
17
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
2015
269
0.030
 Why?
Integrin alpha6
1
2013
9
0.030
 Why?
Mass Spectrometry
1
2017
728
0.030
 Why?
Mammary Glands, Human
1
2014
71
0.030
 Why?
Leukocyte Common Antigens
1
2014
87
0.030
 Why?
Antigens, Differentiation, Myelomonocytic
1
2014
66
0.030
 Why?
Adolescent
3
2024
22825
0.020
 Why?
Parity
1
2014
112
0.020
 Why?
Neovascularization, Pathologic
1
1995
287
0.020
 Why?
Immunoassay
1
1994
109
0.020
 Why?
Anilides
1
2014
84
0.020
 Why?
Transplantation, Heterologous
1
2014
170
0.020
 Why?
Premenopause
1
2014
129
0.020
 Why?
Neoplasm Transplantation
1
2014
246
0.020
 Why?
Testosterone
1
2017
417
0.020
 Why?
bcl-2-Associated X Protein
2
2007
53
0.020
 Why?
Tomography, X-Ray Computed
1
2024
2791
0.020
 Why?
Sirolimus
2
2006
283
0.020
 Why?
Organ Specificity
1
2013
310
0.020
 Why?
Interleukin-6
1
2017
784
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2013
46
0.020
 Why?
Immune System
1
2014
181
0.020
 Why?
Lactation
1
2014
195
0.020
 Why?
Lipogenesis
1
2012
62
0.020
 Why?
Brain Neoplasms
2
1993
1338
0.020
 Why?
Point Mutation
1
1993
245
0.020
 Why?
Molecular Targeted Therapy
1
2015
444
0.020
 Why?
Tumor Necrosis Factor-alpha
2
2007
1224
0.020
 Why?
Broad Ligament
1
1991
1
0.020
 Why?
Astrocytoma
1
1993
131
0.020
 Why?
Neoplasms
2
2012
2946
0.020
 Why?
Gene Knockdown Techniques
1
2013
334
0.020
 Why?
Peritoneum
1
1991
43
0.020
 Why?
Mucins
1
1991
75
0.020
 Why?
Pregnancy Complications, Neoplastic
1
1991
64
0.020
 Why?
Blotting, Northern
1
2010
203
0.020
 Why?
Glycolysis
1
2012
341
0.020
 Why?
Evaluation Studies as Topic
1
1991
164
0.020
 Why?
Hormones
1
1991
136
0.020
 Why?
Cells, Cultured
2
2013
4169
0.020
 Why?
In Situ Hybridization
1
2010
318
0.020
 Why?
Soft Tissue Neoplasms
1
1991
133
0.020
 Why?
Precipitin Tests
1
1989
90
0.020
 Why?
Pilot Projects
1
2015
1912
0.020
 Why?
Pregnancy
2
2014
7274
0.020
 Why?
Radionuclide Imaging
1
1989
116
0.020
 Why?
Odds Ratio
1
1992
1084
0.020
 Why?
Glioblastoma
1
1993
354
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
751
0.020
 Why?
Protein Multimerization
1
2010
205
0.020
 Why?
Risk Factors
1
2003
11017
0.020
 Why?
Lymph Nodes
1
1991
514
0.020
 Why?
Drug Interactions
1
2009
405
0.020
 Why?
Cytochromes c
1
2007
53
0.020
 Why?
Membrane Potential, Mitochondrial
1
2007
75
0.020
 Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
 Why?
Caspase 10
1
2006
5
0.020
 Why?
Caspase 2
1
2006
12
0.020
 Why?
Amino Acid Sequence
3
1998
2134
0.020
 Why?
Caspase 8
1
2006
48
0.020
 Why?
Caspase 9
1
2006
55
0.020
 Why?
Cysteine Endopeptidases
1
2006
80
0.010
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
17
0.010
 Why?
Caspase 7
1
2006
22
0.010
 Why?
Isoenzymes
1
2007
296
0.010
 Why?
Eukaryotic Initiation Factor-4E
1
2006
32
0.010
 Why?
Vero Cells
1
2006
83
0.010
 Why?
Cytosol
1
2006
213
0.010
 Why?
Base Sequence
2
2003
2175
0.010
 Why?
Biomarkers
1
2017
4351
0.010
 Why?
Promoter Regions, Genetic
1
2010
1253
0.010
 Why?
Virus Assembly
1
2006
82
0.010
 Why?
Taxoids
1
2004
116
0.010
 Why?
Protein Binding
1
2010
2249
0.010
 Why?
DNA, Complementary
1
2003
273
0.010
 Why?
Protein Processing, Post-Translational
1
2006
480
0.010
 Why?
Melanoma, Experimental
1
2003
109
0.010
 Why?
Americas
1
2002
27
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2002
25
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
78
0.010
 Why?
Endothelial Growth Factors
1
2002
62
0.010
 Why?
Lymphokines
1
2002
128
0.010
 Why?
Plasminogen Activator Inhibitor 1
1
2002
85
0.010
 Why?
Platelet Membrane Glycoproteins
1
2002
31
0.010
 Why?
Cell Adhesion
1
2003
451
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
50
0.010
 Why?
Gene Targeting
1
2002
81
0.010
 Why?
Exons
2
1993
365
0.010
 Why?
Mice, Inbred C57BL
2
2003
6041
0.010
 Why?
Europe
1
2002
426
0.010
 Why?
Templates, Genetic
1
2001
63
0.010
 Why?
Molecular Sequence Data
2
1998
2886
0.010
 Why?
Substrate Specificity
1
2002
387
0.010
 Why?
DNA, Superhelical
1
2000
12
0.010
 Why?
DNA Footprinting
1
2000
33
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2002
376
0.010
 Why?
Mice, Inbred BALB C
1
2003
1266
0.010
 Why?
Data Interpretation, Statistical
1
2002
369
0.010
 Why?
Genes, erbB
1
2000
2
0.010
 Why?
Ploidies
1
2000
21
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
118
0.010
 Why?
Macromolecular Substances
1
2000
216
0.010
 Why?
Pathology, Clinical
1
2000
29
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2002
552
0.010
 Why?
Gene Silencing
1
2000
203
0.010
 Why?
Forecasting
1
2000
391
0.010
 Why?
Multicenter Studies as Topic
1
2000
417
0.010
 Why?
Genetic Therapy
1
2000
317
0.010
 Why?
Receptors, Cell Surface
1
2000
373
0.010
 Why?
Nucleic Acid Conformation
1
2000
726
0.010
 Why?
Binding Sites
1
2000
1319
0.010
 Why?
Chromosomes, Human, Pair 13
1
1996
15
0.010
 Why?
ras Proteins
1
1998
153
0.010
 Why?
Chromosomes, Human, Pair 3
1
1996
43
0.010
 Why?
Chromosomes, Human, Pair 11
1
1996
60
0.010
 Why?
Immunoblotting
1
1997
296
0.010
 Why?
Heterozygote
1
1996
317
0.010
 Why?
Hyaluronic Acid
1
1998
226
0.010
 Why?
Societies, Medical
1
2000
914
0.010
 Why?
Adenine
1
1998
339
0.010
 Why?
Polymorphism, Single-Stranded Conformational
1
1995
26
0.010
 Why?
Protein Isoforms
1
1997
398
0.010
 Why?
Cyclin D1
1
1995
64
0.010
 Why?
Melanoma
1
2002
774
0.010
 Why?
Factor VIII
1
1995
107
0.010
 Why?
Single-Blind Method
1
1995
319
0.010
 Why?
Observer Variation
1
1995
358
0.010
 Why?
United States
2
2004
16313
0.010
 Why?
Transcription, Genetic
1
2000
1456
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1776
0.010
 Why?
Alleles
1
1996
909
0.010
 Why?
Biopsy
1
1995
1093
0.010
 Why?
Proliferating Cell Nuclear Antigen
1
1991
48
0.010
 Why?
Peripheral Nerves
1
1991
72
0.000
 Why?
Polymorphism, Genetic
1
1993
615
0.000
 Why?
DNA
1
1996
1444
0.000
 Why?
Risk Assessment
1
2000
3784
0.000
 Why?
Protein Conformation
1
1993
943
0.000
 Why?
Lung Neoplasms
1
2002
2679
0.000
 Why?
Cerebral Cortex
1
1991
483
0.000
 Why?
Glioma
1
1991
432
0.000
 Why?
Child
1
1993
22979
0.000
 Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (458) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)